tiprankstipranks
Trending News
More News >
MYND Life Sciences (TSE:MYND)
:MYND

MYND Life Sciences (MYND) Price & Analysis

Compare
20 Followers

MYND Stock Chart & Stats

C$0.07
-C$0.03(-30.00%)
At close: 4:00 PM EST
C$0.07
-C$0.03(-30.00%)

MYND FAQ

What was MYND Life Sciences’s price range in the past 12 months?
MYND Life Sciences lowest stock price was C$0.03 and its highest was C$0.11 in the past 12 months.
    What is MYND Life Sciences’s market cap?
    MYND Life Sciences’s market cap is C$3.35M.
      When is MYND Life Sciences’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were MYND Life Sciences’s earnings last quarter?
      Currently, no data Available
      Is MYND Life Sciences overvalued?
      According to Wall Street analysts MYND Life Sciences’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does MYND Life Sciences pay dividends?
        MYND Life Sciences does not currently pay dividends.
        What is MYND Life Sciences’s EPS estimate?
        MYND Life Sciences’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does MYND Life Sciences have?
        MYND Life Sciences has 47,817,180 shares outstanding.
          What happened to MYND Life Sciences’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of MYND Life Sciences?
          Currently, no hedge funds are holding shares in TSE:MYND
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            MYND Life Sciences

            MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company is headquartered in Kelowna, Canada.

            MYND Life Sciences (MYND) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            BetterLife Pharma
            Cybin
            Entheon Biomedical
            Universal Ibogaine Inc
            Mindbio Therapeutics Corp.
            Popular Stocks